BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 79.60
-0.60 (-0.75%)
Apr 20, 2026, 1:23 PM CST
BIONET Market Cap
BIONET has a market cap or net worth of 4.03 billion as of April 20, 2026. Its market cap has decreased by -5.95% in one year.
Market Cap
4.03B
Enterprise Value
3.73B
Revenue
1.24B
Ranking
n/a
PE Ratio
78.63
Stock Price
79.60
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 4.03B, an increase of 252.81%. That is a compound annual growth rate of 7.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.03B | -22.51% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 242.37B |
| Caliway Biopharmaceuticals | 168.09B |
| Lotus Pharmaceutical | 61.63B |
| Heron Neutron Medical | 61.19B |
| Medigen Biotechnology | 4.25B |
| Sagittarius Life Science | 4.19B |
| Orient EuroPharma | 4.11B |
| Bonraybio | 4.09B |